Posted by Michael Wonder on 11 Dec 2023
SMC - December 2023 decisions
11 December 2023 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice on seven medicines.
Trastuzumab deruxtecan (Enhertu) was accepted for treating adults with a type of breast cancer called HER2 low. It is the first medicine to be licensed for this type of breast cancer.
